ArticleOncology letters2018

Construction of an anti-programmed death-ligand 1 chimeric antigen receptor and determination of its antitumor function with transduced cells.

Jiasen Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.